New Legislation Aims to Improve Coverage for Breast Cancer Detection

New Legislation Aims to Improve Coverage for Breast Cancer Detection

  Breast cancer is a leading cause of death among women worldwide. Early detection is key to improving outcomes for those who develop the disease. To that end, U.S. House lawmakers are proposing a bill that would require all insurers to cover any supplemental breast imaging, beyond screening mammograms, with no patient out-of-pocket costs. The…

Read More

New FDA Recommendation for Women with Dense Breast Tissue

New FDA Recommendation for Women with Dense Breast Tissue

The U.S. Food and Drug Administration updated their mammography standards in early March to require imaging providers to inform women that they have dense breasts and advise them to consult their physician about the potential risks breast density poses. The FDA observed a “steep decrease in the number of facilities that do not meet quality…

Read More

ACR Launches Contrast-Enhanced Mammography Screening Trial for Women with Dense Breasts

ACR Launches Contrast-Enhanced Mammography Screening Trial for Women with Dense Breasts

The American College of Radiology (ACR), in collaboration with the Breast Cancer Research Foundation (BCRF) and GE Healthcare, is about to launch the Contrast-Enhanced Mammography Imaging Screening Trial (CMIST). The trial aims to ascertain whether contrast-enhanced mammography increases breast cancer detection and lowers false positives in women with dense breasts. Dense breasts account for 43%…

Read More